Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8735 |
High Similarity |
NPD8313 |
Approved |
0.8735 |
High Similarity |
NPD8312 |
Approved |
0.8596 |
High Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8363 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.8221 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD6534 |
Approved |
0.8182 |
Intermediate Similarity |
NPD6535 |
Approved |
0.8177 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.8177 |
Intermediate Similarity |
NPD8319 |
Approved |
0.8176 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.8125 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.8122 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.8107 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8075 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8059 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8057 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8056 |
Intermediate Similarity |
NPD6778 |
Approved |
0.8056 |
Intermediate Similarity |
NPD6780 |
Approved |
0.8056 |
Intermediate Similarity |
NPD6776 |
Approved |
0.8056 |
Intermediate Similarity |
NPD6782 |
Approved |
0.8056 |
Intermediate Similarity |
NPD6779 |
Approved |
0.8056 |
Intermediate Similarity |
NPD6781 |
Approved |
0.8056 |
Intermediate Similarity |
NPD6777 |
Approved |
0.8045 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.8045 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.8024 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7964 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7953 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7927 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7919 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7901 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7892 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7861 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7861 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7861 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7836 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7826 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7826 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7821 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7821 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7821 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7821 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7818 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7812 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7807 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7772 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7754 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7733 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7725 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7719 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7719 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7711 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7684 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7654 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7654 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7654 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD37 |
Approved |
0.7651 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7651 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7625 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7619 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7619 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7616 |
Intermediate Similarity |
NPD1470 |
Approved |
0.756 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7557 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7553 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7462 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7455 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7453 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7425 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7384 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7378 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7329 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7294 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7284 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7267 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7261 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7257 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7253 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7205 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD5710 |
Approved |
0.72 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7195 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7193 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7186 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1511 |
Approved |
0.716 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.716 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7108 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7108 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7098 |
Intermediate Similarity |
NPD7999 |
Approved |
0.7091 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7063 |
Intermediate Similarity |
NPD943 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7053 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7019 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7006 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD8361 |
Approved |
0.6989 |
Remote Similarity |
NPD8360 |
Approved |
0.6987 |
Remote Similarity |
NPD1283 |
Approved |
0.6981 |
Remote Similarity |
NPD7008 |
Discontinued |
0.6978 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6974 |
Remote Similarity |
NPD9545 |
Approved |
0.6968 |
Remote Similarity |
NPD1608 |
Approved |
0.6963 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD5736 |
Approved |
0.6957 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD9493 |
Approved |
0.6949 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6947 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD1164 |
Approved |
0.694 |
Remote Similarity |
NPD5034 |
Approved |
0.694 |
Remote Similarity |
NPD4954 |
Approved |
0.694 |
Remote Similarity |
NPD5028 |
Approved |
0.694 |
Remote Similarity |
NPD36 |
Approved |
0.694 |
Remote Similarity |
NPD5026 |
Approved |
0.694 |
Remote Similarity |
NPD4955 |
Approved |
0.6937 |
Remote Similarity |
NPD3268 |
Approved |
0.6937 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6909 |
Remote Similarity |
NPD5762 |
Approved |
0.6909 |
Remote Similarity |
NPD5763 |
Approved |
0.6907 |
Remote Similarity |
NPD7680 |
Approved |
0.6901 |
Remote Similarity |
NPD1653 |
Approved |
0.6899
|
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |